|
RABGEF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.75830494398133E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02649999611515E-09 |
| Normal-vs-Stage2 |
1.331570E-02 |
| Normal-vs-Stage3 |
8.62430127313019E-11 |
| Normal-vs-Stage4 |
2.39289998926751E-09 |
| Stage1-vs-Stage2 |
1.704060E-02 |
| Stage1-vs-Stage3 |
2.823600E-02 |
| Stage1-vs-Stage4 |
3.716000E-02 |
| Stage2-vs-Stage3 |
6.973100E-04 |
| Stage2-vs-Stage4 |
1.116810E-03 |
| Stage3-vs-Stage4 |
7.267400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.65080221398762E-11 |
| Normal-vs-AfricanAmerican |
6.17309999999538E-05 |
| Normal-vs-Asian |
5.86870000000017E-05 |
| Caucasian-vs-AfricanAmerican |
7.674600E-01 |
| Caucasian-vs-Asian |
3.644800E-01 |
| AfricanAmerican-vs-Asian |
3.937000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.27010002304706E-09 |
| Normal-vs-Female |
2.47360021354837E-10 |
| Male-vs-Female |
4.615000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.97150000056124E-08 |
| Normal-vs-Age(41-60Yrs) |
2.08929999967467E-08 |
| Normal-vs-Age(61-80Yrs) |
8.12669931349319E-11 |
| Normal-vs-Age(81-100Yrs) |
7.579900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.718200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.092100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.093400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.037600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.104800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.125800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.580400E-03 |
| Classical-VS-Follicular |
4.345000E-01 |
| Classical-VS-Other |
6.523400E-01 |
| Classical-VS-Normal |
1.3438999912907E-09 |
| Tall-VS-Follicular |
6.897000E-03 |
| Tall-VS-Other |
3.240600E-01 |
| Tall-VS-Normal |
6.29859997491877E-09 |
| Follicular-VS-Other |
5.302200E-01 |
| Follicular-VS-Normal |
3.68929999999823E-05 |
| Other-VS-Normal |
1.048480E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.397000004566E-08 |
| Normal-vs-N1 |
4.70880000547069E-08 |
| N0-vs-N1 |
1.473630E-01 |
|
|
